Glaxosmithkline Share News (GSK)

London close: Stocks jump on gains in big pharma and rally in oil prices

(ShareCast News) - London stocks advanced on Wednesday as oil prices regained strength and investors awaited the Federal Reserve's meeting minutes, which were due out later in the day. Oil prices rose, lifted by a 'bullish' report on the state of weekly US stockpiles of commercial crude. Hopes t

LONDON MARKET CLOSE: Oil Fuels FTSE Rise As Focus Moves To Fed Minutes

London-listed pharmas rally as Pfizer-Allergan deal collapses

(ShareCast News) - Shares in pharmaceuticals companies Shire, AstraZeneca and GlaxoSmithKline rallied on Wednesday as investors bet that the termination of Pfizer's agreement to buy Allergan might make the London-listed companies bid targets. US drug maker Pfizer said on Wednesday that its $160bn ag

Tuesday broker round-up

(ShareCast News) - Royal Mail: Investec reiterates buy with a target price of 580p. Gooch Housego: Investec reiterates buy, 1020p target and Finncap keeps at hold. Glencore: Exane BNP Paribas maintains outperform with a target price of 165p. Babcock: JP Morgan reiterates overweight with a targe

GSK receives European and CHMP approval for stem cell gene therapy

(ShareCast News) - GlaxoSmithKline has been given encouraging support for a stem cell gene therapy that uses an individual patient's own cells to treat a very rare immunodeficiency disorder in children. The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA),

Europe gives green light to first gene therapy for children

By Ben Hirschler LONDON, April 1 (Reuters) - The world's first life-saving gene therapy for children, developed by Italian scientists and GlaxoSmithKline, has been recommended for approval in Europe, boosting the pioneering technology to fix faulty genes. The European Medicines Agency

GlaxoSmithKline Receives Positive Opinion For Strimvelis Gene Therapy

GlaxoSmithKline to drop patents in world's poorest countries

(ShareCast News) - London-listed pharmaceuticals giant GlaxoSmithKline said on Thursday that it is evolving its graduated approach to filing and enforcing patents so that IP protection reflects a country's wealth. In a statement ahead of a meeting of the UN High Level Panel on Access to Medicines, G

GlaxoSmithKline Plans To Waive Patents In World's Poorest Countries

Experts warn complacency on Ebola may leave vaccine work unfinished

By Kate Kelland LONDON, March 31 (Reuters) - The World Health Organization (WHO) has declared the Ebola emergency over, but action is still needed to fully develop effective vaccines and prepare the world for future outbreaks, experts said on Thursday. Great progress has been made in

Decline in financial settlements with U.S. Big Pharma -report

By Sarah N. Lynch WASHINGTON, March 31 (Reuters) - The amount of money big U.S. pharmaceutical manufacturers have paid to settle charges for violating federal health care laws has declined sharply in recent years, prompting a non-profit watchdog group to call for an increase in enforcement

LONDON MARKET CLOSE: Commodity Stocks Support Rally On Weak Dollar

Wednesday broker round-up

(ShareCast News) - Inmarsat: Berenberg upgrades to hold with a target price of 890p. Next: Investec downgrades to sell, 5250p target, Jefferies reiterates hold with a target price of 5100p, JP Morgan stays at neutral with a target of 6370p and HSBC keeps at hold, 6260p target. Glaxosmithkline: Citi

LONDON MARKET MIDDAY: Weak Dollar Prompts Commodity-Supported Rally

WINNERS & LOSERS SUMMARY: McCormick Spices Up Offer For Premier Foods